Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq Capital Market today under the symbol “RNAZ.” The company is looking to raise an aggregate sum of US$25.0 million in its initial public offering.

The offering will consist of 6,250,000 common shares priced at US$4.00 per share. The underwriters were also granted a 45-day over-allotment option to purchase an additional 937,500 common shares at the same offering price, bringing the possible proceeds of the offering to US$28.8 million.

In its statement, TransCode refers to itself as an RNA oncology company centered on the belief that cancer can be addressed through RNA therapeutics. Proceeds from the offering will be intended to progress the trial and develop its therapeutic candidate, TTX-MC138, which is focused on treating metastatic cancer.

Nord Precious Metals — sponsored Sponsored · Nord Precious Metals

The offering is expected to close on July 13, 2021, subject to customary closing conditions. Fordham Financial division ThinkEquity acts as the sole underwriter for the offering.


Information for this briefing was found via Sedar and TransCode. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Air Sanitation Manufacturer AeroClean Technologies Prices US$25 Million IPO

Pathogen elimination technology company AeroClean Technologies, Inc. (Nasdaq: AERC) started publicly trading on the Nasdaq...

Wednesday, November 24, 2021, 02:19:00 PM

Accounts Payable Software AvidXchange Prices US$660 Million IPO

Accounts payable automation software AvidXchange Holdings, Inc. (Nasdaq: AVDX) started publicly trading on the Nasdaq...

Wednesday, October 13, 2021, 02:13:00 PM

OLX Founder-Led Tech SPAC Global Technology Acquisition Closes US$200.0 Million IPO

Special purpose acquisition company Global Technology Acquisition Corp. I (Nasdaq: GTACU) closed on Monday its...

Tuesday, October 26, 2021, 02:07:00 PM

Fintech Firm-Backed SPAC FTAC Emerald Acquisition Prices US$220 Million IPO

Special purpose acquisition company FTAC Emerald Acquisition Corp. (Nasdaq: EMLDU) started trading publicly on the...

Thursday, December 16, 2021, 02:22:00 PM

Biopharmaceutical Firm Candel Therapeutics Prices Downsized US$72 Million IPO

Late clinical stage biopharmaceutical company Candel Therapeutics Inc. (Nasdaq: CADL) started publicly trading on the...

Tuesday, July 27, 2021, 10:47:00 AM